Literature DB >> 3903064

Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors.

L J Ettinger, D Sinniah, S E Siegel, L S Fishman, H D Segall, D Soni, G A Bennetts, D H Schultz, D Raphael.   

Abstract

The chemotherapeutic combination of cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) was used to treat 15 children with recurrent central nervous system tumors and seven children with newly diagnosed brainstem tumors. In patients with recurrent tumors, marginal activity was seen in various histologic types. COPP chemotherapy was clearly ineffective in patients with brainstem tumors. Toxicity consisted of mild to moderate myelosuppression and neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903064     DOI: 10.1007/bf00165188

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

1.  Incidence of malignant tumors in U. S. children.

Authors:  J L Young; R W Miller
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

Review 2.  Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980.

Authors:  H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-07       Impact factor: 7.038

3.  BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.

Authors:  M D Walker; B S Hurwitz
Journal:  Cancer Chemother Rep       Date:  1970-08

4.  Phase II study of cisplatin in recurrent astrocytomas in adults: a Southwest Oncology Group Study.

Authors:  D J Stewart; R M O'Bryan; M Al-Sarraf; J J Costanzi; N Oishi
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

5.  Cyclophosphamide (Cytoxan) therapy of childhood neuroblastoma. Preliminary report.

Authors:  S B KONTRAS; W A NEWTON
Journal:  Cancer Chemother Rep       Date:  1961-06

6.  Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified Phase II trial.

Authors:  J C Allen; L Helson; B Jereb
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

7.  Combination chemotherapy with vincristine (NSC-67574), procarbazine (NSC-77213), prednisone (NSC-10023) with or without nitrogen mustard (NSC-762)(MOPP vs OPP) in children with recurrent brain tumors.

Authors:  A Cangir; A H Ragab; P Steuber; V J Land; D H Berry; J P Krischer
Journal:  Med Pediatr Oncol       Date:  1984

8.  Chemotherapy as an adjunct in the initial management of cerebellar medulloblastomas. A preliminary report.

Authors:  J L Venes; S McIntosh; R T O'Brien; A D Schwartz
Journal:  J Neurosurg       Date:  1979-06       Impact factor: 5.115

9.  High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children.

Authors:  J C Allen; L Helson
Journal:  J Neurosurg       Date:  1981-11       Impact factor: 5.115

10.  Cisplatin therapy in recurrent childhood brain tumors.

Authors:  A B Khan; B J D'Souza; M D Wharam; L A Champion; L F Sinks; S Y Woo; D C McCullough; B G Leventhal
Journal:  Cancer Treat Rep       Date:  1982-12
View more
  7 in total

Review 1.  Salvage chemotherapy for metastatic and recurrent ependymoma of childhood.

Authors:  Eric Bouffet; Michael Capra; Ute Bartels
Journal:  Childs Nerv Syst       Date:  2009-04-10       Impact factor: 1.475

Review 2.  Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy.

Authors:  M T Jennings; M L Freeman; M J Murray
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 3.  The chemotherapy of posterior fossa tumors in childhood.

Authors:  H S Friedman; W J Oakes
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 4.  Pharmacotherapy of malignant astrocytomas of children and adults: current strategies and future trends.

Authors:  M T Jennings; S Iyengar
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial.

Authors:  Didier Frappaz; Matthias Schell; Philippe Thiesse; Perrine Marec-Bérard; Carmine Mottolese; David Perol; Christophe Bergeron; Thierry Philip; Anne Claire Ricci; Sophie Galand-Desme; Alexandru Szathmari; Christian Carrie
Journal:  Neuro Oncol       Date:  2008-06-24       Impact factor: 12.300

Review 6.  Childhood ependymoma: a systematic review of treatment options and strategies.

Authors:  Jacques Grill; Chastagner Pascal; Kalifa Chantal
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents.

Authors:  B A Teicher; S A Holden; K Menon; R E Hopkins; M S Gawryl
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.